Kimberly Clark (KMB) AI Stock Analysis

• Market Cap: $43.36B
• Dividend Yield: 3.86%
• Average Volume (3M): 2.31M
• Price to Earnings (P/E): 17.8
• Beta (1Y): 0.14
• Revenue Growth: -3.12%
• EPS Growth: 34.80%
• Country: US
• Employees: 38,000
• Sector: Consumer Defensive
• Sector Strength: 63
• Industry: Household & Personal Products
• EPS (TTM): 1.93
• Shares Outstanding: 331,816,040
• 10 Day Avg. Volume: 2,103,620
• 30 Day Avg. Volume: 2,308,501
• PEG Ratio: 3.64
• Price to Book (P/B): 83.73
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 24.66
• Enterprise Value/Market Cap: 1.24
• Enterprise Value/Revenue: 0.67
• Enterprise Value/Gross Profit: 7.68
• Enterprise Value/Ebitda: 3.43
• 1Y Price Target: $146.27
• Price Target Upside: 14.31% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 11

• Rating: 68 Neutral
• Price Target: $147.00 ▲(14.88%Upside)

Kimberly Clark's overall score reflects solid financial health and strong cash flow management, despite revenue growth challenges. The stock's valuation is supported by a reasonable P/E ratio and attractive dividend yield. Recent corporate events and strategic initiatives like the joint venture with Suzano and product innovations provide a positive outlook. However, technical indicators suggest slight bearish momentum, and tariff impacts present ongoing risks.

Positive Factors

Sales Growth

KMB is beginning to execute on its transformation, with organic sales led by volume growth, cost savings, and market share gains.

Talent Acquisition

The company is hiring talented outsiders to restructure the organization and improve global coordination, which could enhance their competitive advantage.

Transformation Strategy

KMB's IFP joint venture accelerates transformation and is seen as a significant step in KMB's transformation strategy.

Negative Factors

Consumer Spending

There is acknowledgment of a softer consumer spending environment in the US, which could impact future growth.

Currency Headwinds

Earnings are expected to be pressured by worsening foreign exchange headwinds, with EPS projected to take a 350–400 basis point hit from currency translation.

Tariff Impact

Tariffs remain a key headwind to EBIT and EPS growth for the year, also the primary driver behind recently lowered guidance.

Kimberly Clark Business Overview & Revenue Model

Company Description

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

How the Company Makes Money

Kimberly-Clark makes money primarily through the manufacture and sale of personal care and consumer tissue products. The company's revenue model is centered on its strong brand portfolio, which includes leading names in diapers, tissues, and feminine care products. Kimberly-Clark generates revenue from multiple channels, including retail sales through supermarkets, drugstores, and other retail outlets, as well as direct sales to businesses and institutions in its professional segment. Key revenue streams include consumer tissue products such as Kleenex tissues and Scott paper towels, personal care items like Huggies diapers and Kotex feminine products, and professional health and hygiene products. The company also benefits from strategic partnerships and collaborations with retailers and distributors to expand its market reach and optimize its supply chain efficiencies.

Kimberly Clark Financial Statement Overview

Summary

Kimberly Clark demonstrates solid financial health with strong margins and cash flow performance despite recent revenue declines. The high leverage is a notable risk, but the company effectively uses its equity, as shown by the high ROE. While revenue growth is a concern, the company's operational efficiency and cash management support its continued stability and profitability.

Income Statement

Kimberly Clark's TTM (Trailing-Twelve-Months) gross profit margin is approximately 35.5%, indicating strong profitability in the current period. The TTM net profit margin stands at about 9.6%, showing a decrease compared to previous annual results, which could signal increasing expenses or declining revenue. The revenue growth rate from 2023 to TTM is negative at -3.3%, which raises concerns about declining top-line performance. Despite these challenges, the company maintains a healthy EBIT margin of 16.3% and an EBITDA margin of 18.8% in TTM, demonstrating operational efficiency.

Balance Sheet

The company's debt-to-equity ratio is high at 5.89, indicating significant leverage, which poses financial risk. However, the return on equity (ROE) for TTM is impressive at 172.4%, showcasing exceptional shareholder returns. The equity ratio is low at 6.8%, emphasizing reliance on debt financing. Overall, while the high leverage is concerning, the strong ROE mitigates some risk by reflecting effective use of equity.

Cash Flow

Kimberly Clark has managed a robust free cash flow to net income ratio of 1.37 in TTM, highlighting strong cash generation relative to profits. The operating cash flow to net income ratio is 1.65, further indicating healthy cash flow management. The free cash flow grew by 3.3% from 2024 to TTM, signaling stable cash flow generation despite revenue challenges. Overall, the company's cash flow performance is solid, reflecting its capability to sustain operations and return value to shareholders.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
19.75B	20.06B	20.43B	20.18B	19.44B	19.14B
	Gross Profit
7.00B	7.18B	7.03B	6.22B	5.99B	6.82B
	EBIT
3.21B	3.21B	2.34B	2.68B	2.56B	3.24B
	EBITDA
3.93B	3.98B	3.07B	3.38B	3.25B	3.98B
	Net Income Common Stockholders
2.46B	2.54B	1.76B	1.93B	1.81B	2.35B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
563.00M	1.02B	1.09B	427.00M	270.00M	303.00M
	Total Assets
16.30B	16.55B	17.34B	17.97B	17.84B	17.52B
	Total Debt
7.25B	7.57B	8.11B	8.42B	8.57B	8.36B
	Net Debt
6.68B	6.55B	7.02B	8.00B	8.30B	8.06B
	Total Liabilities
15.08B	15.57B	16.28B	17.27B	17.10B	16.65B
	Stockholders Equity
1.10B	840.00M	915.00M	547.00M	514.00M	626.00M
Cash Flow		Free Cash Flow
2.39B	2.51B	2.78B	1.86B	1.72B	2.51B
	Operating Cash Flow
3.12B	3.23B	3.54B	2.73B	2.73B	3.73B
	Investing Cash Flow
81.00M	-100.00M	-418.00M	-785.00M	-1.06B	-2.31B
	Financing Cash Flow
-3.36B	-3.17B	-2.37B	-1.76B	-1.70B	-1.57B

Kimberly Clark Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 127.96
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KMB, the sentiment is Negative. The current price of 127.96 is below the 20-day moving average (MA) of 136.64, below the 50-day MA of 135.11, and below the 200-day MA of 134.30, indicating a bearish trend. The MACD of -1.52 indicates Positive momentum. The RSI at 32.60 is Neutral, neither overbought nor oversold. The STOCH value of 2.31 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KMB.

Kimberly Clark Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PG	74 Outperform	$377.19B	25.55	30.29%	2.63%	-0.16%	2.74%
KMB	68 Neutral	$43.36B	17.81	229.84%	3.86%	-3.12%	34.80%
KVUE	68 Neutral	$41.57B	39.48	10.22%	3.79%	-1.18%	-29.18%
CHD	65 Neutral	$24.08B	41.96	13.35%	1.21%	2.18%	-26.08%
Sector *	65 Neutral	$8.77B	15.11	4.67%	3.71%	3.60%	-2.96%
CL	64 Neutral	$73.03B	25.51	977.07%	2.31%	0.98%	12.12%
CLX	64 Neutral	$15.27B	22.25	1176.27%	3.94%	-2.64%	189.29%

Kimberly Clark Corporate Events

Kimberly-Clark Forms Joint Venture with Suzano

On June 5, 2025, Kimberly-Clark announced a strategic partnership with Suzano to form a joint venture focusing on consumer tissue and professional products. This venture will include most of Kimberly-Clark’s International Family Care and Professional business, with Suzano acquiring a 51% interest for approximately $1.7 billion. The transaction aims to enhance operational efficiency and market share, with Kimberly-Clark retaining a 49% stake. This move is expected to sharpen Kimberly-Clark’s focus on higher growth and margin segments, improve shareholder returns, and reduce exposure to volatile input costs. The transaction is anticipated to close in mid-2026, pending regulatory approvals.

The most recent analyst rating on (KMB) stock is a Hold with a $140.00 price target. To see the full list of analyst forecasts on Kimberly Clark stock, see the KMB Stock Forecast page.

Kimberly-Clark Transfers Stock Listing to Nasdaq

On May 19, 2025, Kimberly-Clark Corporation announced its decision to transfer the listing of its common stock from the New York Stock Exchange to Nasdaq, effective May 30, 2025. This strategic move includes amendments to the company’s By-Laws to align with Nasdaq’s requirements, potentially impacting the company’s operations and stock trading dynamics.

The most recent analyst rating on (KMB) stock is a Hold with a $153.00 price target. To see the full list of analyst forecasts on Kimberly Clark stock, see the KMB Stock Forecast page.

Kimberly-Clark Appoints New President and COO

On May 1, 2025, Kimberly-Clark Corporation appointed Russell Torres as President and Chief Operating Officer, entrusting him with the oversight of the company’s business segments and global functions. This strategic leadership change aims to bolster the company’s operational efficiency and market growth. Additionally, Jeffrey Melucci was elected as Chief Strategy, Business Development and Administrative Officer to enhance corporate strategy and development.